Recognition of thrombotic risk of thrombocytosis in iron deficiency

od Al-Samkari, Hanny, Kessler, Craig M., Auerbach, Michael
Wydane w Haematologica (2021)

Consultative hemostasis and thrombosis

od Kitchens, Craig S., Kessler, Craig M., Konkle, Barbara A., Garcia, David A.
Wydane 2019

A second retrospective database analysis confirms prior findings of apparent increased cardiovascular comorbidities in hemophilia A in the United States

od Humphries, Thomas J., Ma, Alice, Kessler, Craig M., Kamalakar, Rajesh, Pocoski, Jennifer
Wydane w Am J Hematol (2016)

Outcomes of Mentored, Grant-Funded Fellowship Training in Hemostasis/Thrombosis: Findings from a Nested Case-Control Survey Study

od Goldenberg, Neil A., Kruse-Jarres, Rebecca, Frick, Neil, Pipe, Steven W., Leissinger, Cindy A., Kessler, Craig M.
Wydane 2011

Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry

od Kessler, Craig M., Ma, Alice D., Al-Mondhiry, Hamid A.B., Gut, Robert Z., Cooper, David L.
Wydane w Blood Coagul Fibrinolysis (2016)

Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hem...

od Ma, Alice D., Kessler, Craig M., Al-Mondhiry, Hamid A.B., Gut, Robert Z., Cooper, David L.
Wydane w Blood Coagul Fibrinolysis (2016)

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

od Huth-Kühne, Angela, Baudo, Francesco, Collins, Peter, Ingerslev, Jørgen, Kessler, Craig M., Lévesque, Hervé, Castellano, Maria Eva Mingot, Shima, Midori, St-Louis, Jean
Wydane 2009

Consensus recommendations for the diagnosis and treatment of acquired hemophilia A

od Collins, Peter, Baudo, Francesco, Huth-Kühne, Angela, Ingerslev, Jørgen, Kessler, Craig M, Castellano, Maria E Mingot, Shima, Midori, St-Louis, Jean, Lévesque, Hervé
Wydane 2010

Pilot Randomized, Non-Inferiority, Cross-Over Trial of Once-Weekly Versus Three Times-Weekly Recombinant Factor VIII Prophylaxis in Adults with Severe Hemophilia A

od Ragni, Margaret V., Yabes, Jonathan G., Fogarty, Patrick F., Josephson, Neil C., Kessler, Craig M., Neff, Anne T., Raffini, Leslie, Brummel-Ziedins, Kathleen, Moore, Charity G.
Wydane w Haemophilia (2016)

Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program

od Lissitchkov, Toshko, Klukowska, Anna, Pasi, John, Kessler, Craig M., Klamroth, Robert, Liesner, Raina J., Belyanskaya, Larisa, Walter, Olaf, Knaub, Sigurd, Bichler, Johann, Jansen, Martina, Oldenburg, Johannes
Wydane w Ther Adv Hematol (2019)

Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model

od Goldenberg, Neil A., Spyropoulos, Alex C., Halperin, Jonathan L., Kessler, Craig M., Schulman, Sam, Turpie, Alexander G. G., Skene, Allan M., Cutler, Neal R., Hiatt, William R.
Wydane 2011

Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial

od Mesa, Ruben A., Silver, Richard T., Verstovsek, Srdan, Mascarenhas, John, Kessler, Craig M., Rondelli, Damiano, Goldberg, Judy D., Marchioli, Roberto, Demakos, Erin P., Silverman, Lewis R., Hoffman, Ronald
Wydane 2013

Von Willebrand Factor for Menorrhagia: A Survey and Literature Review

od Ragni, Margaret V., Machin, Nicoletta, Malec, Lynn M., James, Andra H., Kessler, Craig M., Konkle, Barbara A., Kouides, Peter A., Neff, Anne T., Philipp, Claire S., Brambilla, Donald J.
Wydane w Haemophilia (2016)

Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company

od Hay, Charles R. M., Shima, Midori, Makris, Michael, Jiménez‐Yuste, Victor, Oldenburg, Johannes, Fischer, Kathelijn, Iorio, Alfonso, Skinner, Mark W., Santagostino, Elena, von Mackensen, Sylvia, Kessler, Craig M.
Wydane w Haemophilia (2020)

Balancing Risk and Benefit in Venous Thromboembolism Trials: Concept for a Bivariate Endpoint Trial Design and Analytic Approach

od Kittelson, John M., Spyropoulos, Alex C., Halperin, Jonathan L., Kessler, Craig M., Schulman, Sam, Steg, Gabriel, Turpie, Alexander G. G., Cutler, Neal R., Hiatt, William R., Goldenberg, Neil A.
Wydane w J Thromb Haemost (2013)

Phenotypes of Allo- and Autoimmune Antibody Responses to FVIII Characterized by Surface Plasmon Resonance

od Lewis, Kenneth B., Hughes, Richard J., Epstein, Melinda S., Josephson, Neil C., Kempton, Christine L., Kessler, Craig M., Key, Nigel S., Howard, Tom E., Kruse-Jarres, Rebecca, Lusher, Jeanne M., Walsh, Christopher E., Watts, Raymond G., Ettinger, Ruth A., Pratt, Kathleen P.
Wydane 2013

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism

od Kearon, Clive, Parpia, Sameer, Spencer, Frederick A., Baglin, Trevor, Stevens, Scott M., Bauer, Kenneth A., Lentz, Steven R., Kessler, Craig M., Douketis, James D., Moll, Stephan, Kaatz, Scott, Schulman, Sam, Connors, Jean M., Ginsberg, Jeffrey S., Spadafora, Luciana, Bhagirath, Vinai, Liaw, Patricia C., Weitz, Jeffrey I., Julian, Jim A.
Wydane w Blood (2018)

A cross-sectional analysis of cardiovascular disease in the hemophilia population

od Sood, Suman L., Cheng, Dunlei, Ragni, Margaret, Kessler, Craig M., Quon, Doris, Shapiro, Amy D., Key, Nigel S., Manco-Johnson, Marilyn J., Cuker, Adam, Kempton, Christine, Wang, Tzu-Fei, Eyster, M. Elaine, Kuriakose, Philip, von Drygalski, Annette, Gill, Joan Cox, Wheeler, Allison, Kouides, Peter, Escobar, Miguel A., Leissinger, Cindy, Galdzicka, Sarah, Corson, Marshall, Watson, Crystal, Konkle, Barbara A.
Wydane w Blood Adv (2018)